NAIROBI, Kenya, July 18 – Shalina Healthcare plans to develop its product portfolio in Kenya and throughout African markets.
The pharmaceutical agency is getting ready to launch a diagnostics division in Kenya, aiming to supply reasonably priced, tech-enabled medical testing companies.
“This step is a part of our ongoing dedication to delivering accessible, high-quality healthcare and deepening our long-term impression throughout Africa,” the corporate mentioned in an announcement.
The agency additionally introduced that will probably be introducing new Kaluma product traces within the nation.
Shalina, which was based within the Democratic Republic of Congo and now operates in 25 international locations, entered the Kenyan market in 2018 by way of the acquisition of Pharmaceutical Manufacturing Company (PMC).
Its manufacturing facility in India, whose product portfolio contains prescribed drugs, over-the-counter medicines, and client healthcare, is accredited by Kenya’s Pharmacy and Poisons Board (PPB).
